mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PIR
Gene summary
Basic gene Info.Gene symbolPIR
Gene namepirin (iron-binding nuclear protein)
Synonyms-
CytomapUCSC genome browser: Xp22.2
Type of geneprotein-coding
RefGenesNM_001018109.2,
NM_003662.3,
Descriptionpirinprobable quercetin 2,3-dioxygenase PIRprobable quercetinase
Modification date20141207
dbXrefs MIM : 300931
HGNC : HGNC
Ensembl : ENSG00000087842
HPRD : 04510
Vega : OTTHUMG00000021176
ProteinUniProt: O00625
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PIR
BioGPS: 8544
PathwayNCI Pathway Interaction Database: PIR
KEGG: PIR
REACTOME: PIR
Pathway Commons: PIR
ContextiHOP: PIR
ligand binding site mutation search in PubMed: PIR
UCL Cancer Institute: PIR
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for PIR
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
L114H112DBRCA1
F45K46EOV1
E103P105TUCEC1
M73A74TUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PIR
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
M73A74T-1.0666554
E103P105T-0.63483065
F45K46E-0.46464075
L114H112D-0.21640677
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PIR from PDB

Top
Differential gene expression and gene-gene network for PIR
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PIR and the right PPI network was created from samples without mutations in the LBS of PIR. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PIR
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PIR
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PIR go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
FE2IRON(2+)1j1lAE103
FE2IRON(2+)3aclAE103
COCOBALT(2+)4eroAE103
FEIRON(3+)4ewaAE103
MNMANGANESE(2+)4ewdAE103
MNMANGANESE(2+)4eweAE103
FE2IRON(2+)4gulAE103
FE2IRON(2+)4hltAE103
3F1N-{[4-(BENZYLOXY)PHENYL](METHYL)-LAMBDA}-4-METHYLBENZENESULFONAMIDE3aclAF45 M73 L114


Top
Conservation information for LBS of PIR
Multiple alignments for O00625 in multiple species
LBSAA sequence# speciesSpecies
D43PFLLFDEFKGG3Homo sapiens, Mus musculus, Rattus norvegicus
D43PFLMLDEFSVS1Arabidopsis thaliana
D43PFVLLVEFSFS1Arabidopsis thaliana
D43PFVSLVEFSVS1Arabidopsis thaliana
E103GILHAEMPCSE3Homo sapiens, Mus musculus, Rattus norvegicus
E103GIIHSEMP-EE2Arabidopsis thaliana, Arabidopsis thaliana
E103GIIHSEFP-EE1Arabidopsis thaliana
F45LLFDEFKGGRP2Homo sapiens, Rattus norvegicus
F45LLFDEFKGGKP1Mus musculus
F45LMLDEFSVSPP1Arabidopsis thaliana
F45VLLVEFSFSLS1Arabidopsis thaliana
F45VSLVEFSVSPP1Arabidopsis thaliana
F53GRPGGFPDHPH2Homo sapiens, Rattus norvegicus
F53GKPGGFPDHPH1Mus musculus
F53SPPAGFPDHPH1Arabidopsis thaliana
F53SLSAGFPDHPH1Arabidopsis thaliana
F53SPPGGFKDHPH1Arabidopsis thaliana
H101GRGILHAEMPC3Homo sapiens, Mus musculus, Rattus norvegicus
H101GRGIIHSEMP-2Arabidopsis thaliana, Arabidopsis thaliana
H101GRGIIHSEFP-1Arabidopsis thaliana
H56GGFPDHPHRGF3Homo sapiens, Mus musculus, Rattus norvegicus
H56AGFPDHPHRGF2Arabidopsis thaliana, Arabidopsis thaliana
H56GGFKDHPHRGF1Arabidopsis thaliana
H58FPDHPHRGFET4Homo sapiens, Mus musculus, Rattus norvegicus, Arabidopsis thaliana
H58FPDHPHRGFES1Arabidopsis thaliana
H58FKDHPHRGFES1Arabidopsis thaliana
L114EPAHGLQLWVN3Homo sapiens, Mus musculus, Rattus norvegicus
L114EVNKGLQLWIN1Arabidopsis thaliana
L114EVNNGLQLWIN1Arabidopsis thaliana
L114QVNKGLQLWIN1Arabidopsis thaliana
L41LDPFLLFDEFK3Homo sapiens, Mus musculus, Rattus norvegicus
L41LDPFLMLDEFS1Arabidopsis thaliana
L41LDPFVLLVEFS1Arabidopsis thaliana
L41LDPFVSLVEFS1Arabidopsis thaliana
M73LEGGSMAHEDF3Homo sapiens, Mus musculus, Rattus norvegicus
M73LEGG-ITHQDF1Arabidopsis thaliana
M73LQGG-IIHKDP1Arabidopsis thaliana
M73FQGG-IIHQDC1Arabidopsis thaliana
M85GHVGKMNPGDL2Mus musculus, Rattus norvegicus
M85GHTGKMNPGDL1Homo sapiens
M85GHKGTIYAGDV1Arabidopsis thaliana
M85GHKGTIQAGDV1Arabidopsis thaliana
M85GNKGTIHEGDV1Arabidopsis thaliana
Q115PAHGLQLWVNL3Homo sapiens, Mus musculus, Rattus norvegicus
Q115VNKGLQLWINL2Arabidopsis thaliana, Arabidopsis thaliana
Q115VNNGLQLWINL1Arabidopsis thaliana
S65GFETVSYLLEG3Homo sapiens, Mus musculus, Rattus norvegicus
S65GFETVTYVLEG1Arabidopsis thaliana
S65GFESVTYMLQG1Arabidopsis thaliana
S65GFESVTYMFQG1Arabidopsis thaliana
W117HGLQLWVNLRS1Homo sapiens
W117HGLQLWVNLRR1Mus musculus
W117HGLQLWVNLKR1Rattus norvegicus
W117KGLQLWINLSS1Arabidopsis thaliana
W117NGLQLWINLPS1Arabidopsis thaliana
W117KGLQLWINLPS1Arabidopsis thaliana
Y66FETVSYLLEGG3Homo sapiens, Mus musculus, Rattus norvegicus
Y66FETVTYVLEGG1Arabidopsis thaliana
Y66FESVTYMLQGG1Arabidopsis thaliana
Y66FESVTYMFQGG1Arabidopsis thaliana


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas